Suppr超能文献

[Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?].

作者信息

Recio-Mayoral Alejandro

出版信息

Med Clin (Barc). 2010 Sep 11;135(8):362-4. doi: 10.1016/j.medcli.2010.03.029. Epub 2010 Jun 16.

Abstract
摘要

相似文献

1
[Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?].
Med Clin (Barc). 2010 Sep 11;135(8):362-4. doi: 10.1016/j.medcli.2010.03.029. Epub 2010 Jun 16.
3
Contrast nephropathy: isosmolar and low-osmolar contrast media.对比剂肾病:等渗与低渗对比剂
J Am Coll Cardiol. 2007 Feb 27;49(8):922; author reply 922-3. doi: 10.1016/j.jacc.2006.12.002. Epub 2007 Feb 8.
4
Contrast-induced nephropathy.对比剂肾病
J Med Liban. 2007 Jan-Mar;55(1):29-38.
6
The relative renal safety of iodixanol compared with low-osmolar contrast media.
JACC Cardiovasc Interv. 2009 Nov;2(11):1163-4; author reply 1164. doi: 10.1016/j.jcin.2009.08.022.
7
Contrast-induced nephropathy.
Indian Heart J. 2004 Jan-Feb;56(1):13-20.
8
[Nephropathy, clinical aspects and prevention].
Dtsch Med Wochenschr. 2006 May 5;131(18):1050; author reply 1051. doi: 10.1055/s-2006-939895.
10
Renal safety of iodixanol.碘克沙醇的肾脏安全性。
Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61. doi: 10.1586/14779072.4.5.655.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验